Organ ‐on‐chip models: Implications in drug discovery and clinical applications
In this study, we review the recent advances in in vitro modeling including three‐dimensi onal (3D) organoids, 3D microfabrication, and 3D bioprinting for various organs including the heart, kidney, lung, gastrointestinal tract (intestine–gut–stomach), liver, placenta, adipose, retina, bone, and brain as well as multiorgan models. The availability of organ‐on‐chip models provides a wealth of opportunities to understand the pathogenesis of human diseases and provide a potentially better model to screen a drug, as these models utilize a dynamic 3D environment similar to the human body. Although there are limitations of organ‐on‐chip models, the emergence of new technologi es have refined their capability for translational research as well as precision medicine.
Source: Journal of Cellular Physiology - Category: Cytology Authors: Rahul Mittal,
Frank W. Woo,
Carlo S. Castro,
Madeline A. Cohen,
Joana Karanxha,
Jeenu Mittal,
Tanya Chhibber,
Vasanti M. Jhaveri Tags: REVIEW ARTICLE Source Type: research
More News: Brain | Cardiology | Clinical Trials | Cytology | Environmental Health | Gastroenterology | Heart | Liver | Neurology | Physiology | Study | Urology & Nephrology